Clinical Value of Macrophage Inhibitory Cytokine-1 As a Serum Tumor Marker for Diagnosis of Pancreatic Cancer

ZENG Linshan,XIAO Weidong,LI Yong,CAI Jun,YU Yonghuan,LI Xueming

2011-01-01

Abstract:Objective To assess the clinical value of macrophage inhibitory cytokine-1(MIC-1) as a serum tumor marker for diagnosis of pancreatic cancer.Methods Serum MIC-1 levels were measured by enzyme-linked immunosorbent assay(ELISA) in 35 patients with pancreatic cancer,30 patients with benign pancreatic disease and 30 healthy control subjects.Meanwhile,the results of MIC-1 were compared with that of CA19-9.Results The serum MIC-1 level in patients with pancreatic carcer[(1 589.8±838.5) pg/mL]was significantly higher than that in patients with benign pancreatic diseases [(400.6±104.3) pg/mL] or healthy subjects [(386.1±145.5) pg/mL](both P0.01),while MIC-1 levels exhibited no significant difference between the patients with benign pancreatic diseases and the healthy subjects(P0.05).The sensitivity,specificity,positive predictive value,negative predictive value,and area under the curve(AUC) of receiver operating characteristic curve of MIC-1 measurement for diagnosis of pancreatic cancer were 85.7%,93.3%,93.8%,84.9% and 0.973,respectively,which were all higher than those of the corresponding values of CA19-9(74.3%,90.0%,89.6%,75.0% and 0.862,respectively).The sensitivity and specificity of combined measurement of MIC-1 and CA19-9 was 91.4% and 83.3%,respectively.The positive rate of MIC-1 was significantly lower than that of CA19-9 in patients with benign pancreatic diseases(3.3% vs.26.7%,P0.05).The positive rate of CA19-9 in patients with benign pancreatic diseases complicated by jaundice was significantly higher than that patients without jaundice(55.6% vs.14.3%,P0.05),while whether complicated by jaundice or not,it had no influence on the positive rate of MIC-1(P0.05).Conclusions The comprehensive diagnostic ability of MIC-1 is better than CA19-9 for diagnosis of pancreatic cancer,and MIC-1 may potentially be a novel serum tumor marker of pancreatic cancer.